T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion

被引:203
作者
Shimizu, M [1 ]
Ino, H [1 ]
Okeie, K [1 ]
Yamaguchi, M [1 ]
Nagata, M [1 ]
Hayashi, K [1 ]
Itoh, H [1 ]
Iwaki, T [1 ]
Oe, K [1 ]
Konno, T [1 ]
Mabuchi, H [1 ]
机构
[1] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan
关键词
hypertrophic cardiomyopathy; troponin I; QT dispersion; transmural QT dispersion;
D O I
10.1002/clc.4950250706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with hypertrophic cardiomyopathy (HCM) associated with a deletion of lysine 183 (K183del) in the cardiac troponin I (cTnI) gene suffer sudden cardiac death at all ages. However, the correlation between QT variables and sudden cardiac death in these patients remains uncertain. Hypothesis: We evaluated the correlation between QT variables and sudden cardiac death and/or ventricular tachyarrhythmia (SCD/VT) in patients with HCM associated with the cTnI mutation. Methods: We analyzed 10 probands with HCM associated with the cTnI gene K183del and their family members. The subjects were divided into three groups: Group A (n = 7), mutation carriers with SCD/VT; Group B (n = 16), mutation carriers without SCD/VT; Group C (n = 24), no mutation carriers. QT intervals were corrected using Bazett's formula. Results: Maximum QTc and corrected QT dispersion were significantly longer in Groups A and B than in Group C. However, there were no differences in either parameter between Groups A and B. On the contrary, the peak-to-end interval of T wave/QT interval in V-5 (Tpe) in Group A was significantly longer than that in Groups B and C. Logistic regression analysis revealed that Tpe was a good clinical predictor for SCD/VT in patients with HCM in this study. Conclusions: These results suggest that Tpe rather than QT dispersion may be one of the best predictors for SCD/VT in patients with HCM associated with the K183del mutation in the cTnI gene.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 19 条
[1]  
Antzelevitch C, 1997, J ELECTROCARDIOL, V30, P168
[2]   Temporal repolarization lability in hypertrophic cardiomyopathy caused by β-myosin heavy-chain gene mutations [J].
Atiga, WL ;
Fananapazir, L ;
McAreavey, D ;
Calkins, H ;
Berger, RD .
CIRCULATION, 2000, 101 (11) :1237-1242
[3]   QT dispersion in α-myosin heavy-chain familial hypertrophic cardiomyopathy mice [J].
Bevilacqua, LM ;
Maguire, CT ;
Seidman, JG ;
Seidman, CE ;
Berul, CI .
PEDIATRIC RESEARCH, 1999, 45 (05) :643-647
[4]   COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN-DEATH [J].
BUJA, G ;
MIORELLI, M ;
TURRINI, P ;
MELACINI, P ;
NAVA, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (12) :973-976
[5]   Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene [J].
Charron, P ;
Dubourg, O ;
Desnos, M ;
Bennaceur, M ;
Carrier, L ;
Camproux, AC ;
Isnard, R ;
Hagege, A ;
Langlard, JM ;
Bonne, G ;
Richard, P ;
Hainque, B ;
Bouhour, JB ;
Schwartz, K ;
Komajda, M .
CIRCULATION, 1998, 97 (22) :2230-2236
[6]   QT-INTERVAL ABNORMALITIES IN HYPERTROPHIC CARDIOMYOPATHY [J].
DRITSAS, A ;
SBAROUNI, E ;
GILLIGAN, D ;
NIHOYANNOPOULOS, P ;
OAKLEY, CM .
CLINICAL CARDIOLOGY, 1992, 15 (10) :739-742
[7]   GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS [J].
FANANAPAZIR, L ;
EPSTEIN, ND .
CIRCULATION, 1994, 89 (01) :22-32
[8]   Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy [J].
Kimura, A ;
Harada, H ;
Park, JE ;
Nishi, H ;
Satoh, M ;
Takahashi, M ;
Hiroi, S ;
Sasaoka, T ;
Ohbuchi, N ;
Nakamura, T ;
Koyanagi, T ;
Hwang, TH ;
Choo, TA ;
Chung, KS ;
Hasegawa, A ;
Nagai, R ;
Okazaki, O ;
Nakamura, H ;
Matsuzaki, M ;
Sakamoto, T ;
Toshima, H ;
Koga, Y ;
Imaizumi, T ;
Sasazuki, T .
NATURE GENETICS, 1997, 16 (04) :379-382
[9]   Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene [J].
Kokado, H ;
Shimizu, M ;
Yoshio, H ;
Ino, H ;
Okeie, K ;
Emoto, Y ;
Matsuyama, T ;
Yamaguchi, M ;
Yasuda, T ;
Fujino, N ;
Ito, H ;
Mabuchi, H .
CIRCULATION, 2000, 102 (06) :663-669
[10]  
Maron BJ, 2000, CIRCULATION, V102, P858